MIRADOR BIOMEDICAL
Mirador Biomedical's team of experienced entrepreneurs and seasoned medical device professionals are partnering with an exceptional group of physicians and scientists to develop innovative, cost effective devices that provide physiological feedback to alleviate doubt and uncertainty during common medical procedures.
MIRADOR BIOMEDICAL
Social Links:
Industry:
Biotechnology Health Care Innovation Management Medical Device
Founded:
2009-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.miradorbiomedical.com
Total Employee:
251+
Status:
Active
Contact:
(206)755-5470
Email Addresses:
[email protected]
Total Funding:
2.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Font Awesome Apache AJAX Libraries API Linode Joomla!
Current Employees Featured
Founder
Investors List
WRF Capital
WRF Capital investment in Series B - Mirador Biomedical
Summit Capital
Summit Capital investment in Series B - Mirador Biomedical
Karl Schmidt
Karl Schmidt investment in Series A - Mirador Biomedical
Washington Research Foundation
Washington Research Foundation investment in Series A - Mirador Biomedical
Summit Capital
Summit Capital investment in Series A - Mirador Biomedical
Official Site Inspections
http://www.miradorbiomedical.com
- Host name: 74.122.196.210
- IP address: 74.122.196.210
- Location: Saint Paul United States
- Latitude: 44.7499
- Longitude: -93.2081
- Metro Code: 613
- Timezone: America/Chicago
- Postal: 55124
More informations about "Mirador Biomedical"
Company - Mirador Biomedical now part of Centurion Medical …
Williamston, MI — Centurion Medical Products has recently acquired Mirador Biomedical of Seattle, Washington. With the addition of Mirador Biomedical, Centurion continues its …See details»
Home - Mirador Biomedical now part of Centurion …
University of Washington physicians discuss how using Mirador Biomedical’s Compass pressure measurement device can prevent complications from inadvertent arterial cannulation during vascular access. Compass Vascular …See details»
Mirador Biomedical - Crunchbase Company Profile & Funding
Mirador Biomedical develops innovative medical devices to alleviate doubt and uncertainty during common medical procedures. Acquired by Centurion Medical Products CorpSee details»
Team - Mirador Biomedical now part of Centurion Medical Products
Dr. Emily Vandermeer is a leading biomedical scientist with over 20 years of experience in medical product innovation. She holds a PhD in Biomedical Engineering from MIT, where her …See details»
Mirador Biomedical Company Profile 2024: Valuation, …
Information on acquisition, funding, cap tables, investors, and executives for Mirador Biomedical.See details»
Mirador Biomedical, Inc. | Insights
Oct 1, 2024 · Mirador Biomedical Inc. 2815 Eastlake Avenue East Suite 220 Seattle, WA 98102 Phone: (206) 407-3595 Web Site: www.miradorbiomedical.com Contact: Karl Schmidt, CEO …See details»
Mirador Biomedical, Inc.: Drug pipelines, Patents, Clinical trials ...
Jul 16, 2023 · Explore Mirador Biomedical, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Mirador Biomedical Inc - Company Profile and News
Mirador Biomedical, Inc. develops medical devices. The Company offers pressure transducer for central venous catheter insertion that allows physicians to view their hands and patients.See details»
Mirador Biomedical - Overview, News & Similar companies
Mirador Biomedical is a privately held company founded in 2009 in Seattle, Washington to develop the Compassâ„¢ family of medical devices.See details»
Mirador Biomedical - Contacts, Employees, Board Members
Mirador Biomedical develops innovative medical devices to alleviate doubt and uncertainty during common medical procedures.See details»
Mirador Biomedical - VentureRadar
Mirador Biomedical VentureRadar profile. Find out more about Mirador Biomedical including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»
Mirador, a new biotech startup, launches with $400 million
Mar 21, 2024 · Prometheus and some other companies have been able to capitalize on creating treatments for conditions like inflammatory bowel disease and psoriasis, while arthritis …See details»
Mirador – Redefining Immunology & Inflammation with Precision
Sep 27, 2024 · Mirador Therapeutics envisions a bold new era of precision medicine for immune-mediated inflammatory and fibrotic diseases driven by speed and better development …See details»
News - Mirador Biomedical now part of Centurion Medical Products
Oct 9, 2014 · Centurion Medical Products Acquires Mirador Biomedical. Mirador Centurion Announcement. May 28th, 2014. Mirador Receives 510(k) for New Compass Pressure …See details»
Prometheus team returns with brand-new biotech and $400M
Mar 21, 2024 · And now they’re back, with a brand-new biotech called Mirador Therapeutics and a massive $400 million series A funding round—the biggest of 2024 so far. Mirador emerged …See details»
CONFIDENTIAL DRAFT Mirador Therapeutics Launches to …
T, Mirador utilizes Mirador360, its proprietary precision development engine that leverages recent breakthroughs in human genetics and cutting-edge data science. Mirador360 is purpose-built …See details»
Mirador Therapeutics Launches to Accelerate the Next Generation …
Mar 21, 2024 · Founded by Mark C. McKenna and led by several former executives of Prometheus Biosciences (acquired in 2023 by Merck for $10.8 billion), Mirador aims to …See details»
Press Releases - Mirador Biomedical now part of Centurion …
Oct 9, 2014 · Mirador Biomedical receives 510(k) clearance for expanded Compass Platform, launches Thoracentesis and Compartment Pressure monitoring products. Mirador Biomedical …See details»
Precision Immune Start-Up Mirador Launches with $400M+
Mar 25, 2024 · Mirador Therapeutics has launched with more than $400 million through a financing led by ARCH Venture Partners. The start-up aims to “revolutionize precision …See details»
Publications - Mirador Biomedical now part of Centurion Medical …
Arterial Cannulation During Central Line Placement: Mechanisms of Injury, Prevention, and Treatment. Clinical Evaluation of a Novel Sterile Disposable Pressure Transducer with …See details»